Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrotic Lung Disease”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableLooking for participantsNCT06027333
What this trial is testing

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseFibrotic Lung DiseaseSelf Efficacy+3 more
Berner Reha Zentrum AG 80
Large-scale testing (Phase 3)Ended earlyNCT03267108
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon Pulse Technologies 145
Post-approval studies (Phase 4)Looking for participantsNCT06479603
What this trial is testing

RCT of Nintedanib in Fibrotic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
Post Graduate Institute of Medical Education and Research, Chandigarh 120
Not applicableStudy completedNCT05779007
What this trial is testing

Dose Reduction and Discontinuation With Anti-Fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 2,778
Not applicableActive Not RecruitingNCT04680832
What this trial is testing

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

Who this might be right for
Pulmonary Fibrosis
Erasmus Medical Center 600
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Post-approval studies (Phase 4)Not Yet RecruitingNCT07141810
What this trial is testing

Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Shanghai Pulmonary Hospital, Shanghai, China 104
Early research (Phase 1)UnknownNCT00129350
What this trial is testing

Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation

Who this might be right for
EmphysemaAlveolitis, FibrosingCystic Fibrosis+2 more
Royal Brompton & Harefield NHS Foundation Trust 60
Not applicableStudy completedNCT05648734
What this trial is testing

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

Who this might be right for
Post-COVID-19 SyndromeLung Fibrosis
Mansoura University 200
Testing effectiveness (Phase 2)UnknownNCT04805086
What this trial is testing

The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseCovid19
Guy's and St Thomas' NHS Foundation Trust 5
Post-approval studies (Phase 4)UnknownNCT04856111
What this trial is testing

Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia

Who this might be right for
Novel Coronavirus-induced Lung Fibrosis
Post Graduate Institute of Medical Education and Research, Chandigarh 48
Not applicableLooking for participantsNCT05866198
What this trial is testing

Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation

Who this might be right for
Lung Diseases, Interstitial
University of South Florida 70
Testing effectiveness (Phase 2)Looking for participantsNCT03805477
What this trial is testing

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

Who this might be right for
Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
University Hospital, Basel, Switzerland 20
Post-approval studies (Phase 4)UnknownNCT03260556
What this trial is testing

Pirfenidone for Progressive Fibrotic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
University of Cincinnati 60
Post-approval studies (Phase 4)Study completedNCT04619680
What this trial is testing

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseRespiratory Disease
Icahn School of Medicine at Mount Sinai 121
Not applicableStudy completedNCT06016959
What this trial is testing

Specialist Dietetic Intervention in Malnourished Patients with Fibrotic ILD: a Randomised Controlled Pilot Trial

Who this might be right for
Interstitial Lung Disease
Royal Brompton & Harefield NHS Foundation Trust 40
Not applicableNot Yet RecruitingNCT06416163
What this trial is testing

FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion

Who this might be right for
Interstitial Lung DiseaseFibrosis LungPulmonary Hypertension
Guy's and St Thomas' NHS Foundation Trust 160
Testing effectiveness (Phase 2)Looking for participantsNCT06189820
What this trial is testing

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

Who this might be right for
Pulmonary FibrosisLung FibrosisIdiopathic Pulmonary Fibrosis+1 more
Erasme University Hospital 70
Post-approval studies (Phase 4)Active Not RecruitingNCT05799755
What this trial is testing

Myositis Interstitial Lung Disease Nintedanib Trial

Who this might be right for
Myositis Associated Interstitial Lund Disease (MA-ILD)
Rohit Aggarwal, MD 70
Not applicableLooking for participantsNCT07332117
What this trial is testing

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 30
Load More Results